Searchable abstracts of presentations at key conferences in endocrinology

ea0016p475 | Neuroendocrinology | ECE2008

Prolaktinoma and hyperprolactinemia in Albania

Ylli Agron , Ylli Zamira , Minga Malo , Fureraj Thanas , Husi Gerond , Xhumari Arian , Kaloshi Gentian , Alushani Merita , Lamcaj Entela , Olldashi Blertina

Background: Prolactin hyper secretion is the most common endocrine abnormality due to hypothalamic–pituitary disorders. PRL is the hormone most commonly secreted in excess by pituitary adenomas.Materials and methods: A retrospective study was performed during the period 1998–2007. The diagnose are based on objective examination, hormonal dosage, MRI.Results: During these time were diagnosed 98 cases with hyperprolactinemi...

ea0016p759 | Thyroid | ECE2008

Some data about the epidemiology of thyroid cancer in Albania

Ylli Agron , Ylli Zamira , Lamcaj Entela , Olldashi Blertina , Shehu Medi , Furreraj Thanas , Husi Gerond , Celiku Edmond , Agolli Medi , Gjata Arben , Titka Vladimir , Nocka Albert , Karaj Agim

Introduction: Aim: the aim of our study was to give some data about the epidemiology of thyroid cancer in our country.Material and methods: We studied patients diagnosed with thyroid cancer during January 1998–October 2007.Results: We studied 179 patient from 13 to 80 years diagnosed with thyroid cancer during January 1998–October 2007. Median age at dignoses was: 46.2±14.7 years. According to the gender: females wer...

ea0090p63 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Left hemiparesis and urinary incontinence as presentation of pancreatic Insulinoma in a young female. A Case report and review of literature

Cerma Adishah , Kermaj Marjeta , Ylli Agron

Introduction: Insulinoma is a rare tumor, with peak incidence at 30 -60 years of age and more frequent in women. It is associated with a myriad of clinical manifestations: from clearly defined adrenergic and neuroglycopenic symptoms to asymptomatic hypoglycemia. We present the case of a 20-year-old patient with pancreatic insulinoma, which was surgically resected only after her second hospitalization due to repeated negative imaging.Case presentation: A ...

ea0090p786 | Thyroid | ECE2023

Graves’ disease presented simultaneously with subacute thyroiditis - A case report

Lumi Ema , Tare Rajmonda , Ylli Agron

Introduction: Graves’ disease is an autoimmune disease that leads to a generalized over activity of the entire thyroid gland (hyperthyroidism). It is caused by TRAb thyrotropin receptor antibodies (TRAb), which bind to receptors on the surface of thyroid cells and stimulate those cells to overproduce and release thyroid hormones. Subacute thyroiditis is presumed to be caused by a viral infection or a postviral inflammatory process. It is a self-l...

ea0049ep546 | Diabetes complications | ECE2017

Screening for macrovascular complications in diabetic patients in Korça, Albania

Lumi Ema , Ylli Dorina , Ylli Agron

Background: Diabetes mellitus (DM) is a common metabolic disorder and is associated with development of chronic macrovascular complications leading to significant morbidity and mortality. The aim of the study was to evaluate the prevalence and clinical profile of macrovascular complications in diabetic patients in Korca, Albania.Material and methods: A total of 456 cases with type 2 DM attending Department of Endocrine (outpatient/inpatient), from Januar...

ea0070ep346 | Pituitary and Neuroendocrinology | ECE2020

The role of Octreotide in the treatment of acromegaly

Lekbello Megi , Husi Gerond , Ylli Agron

Acromegaly is a rare disorder with a high morbidity and mortality rate. The diagnosis is typically prolonged over time due to a slow and hidden development of the disease. Current medical therapy for the treatment of acromegaly involves the administration of somatostatin analogues that effectively suppress excess hormone secretion. The objective of this study was to investigate the efficacy of octreotide therapy in acromegalic. A total of 32 patients have been treated with Oct...

ea0081ep192 | Calcium and Bone | ECE2022

Fahr Syndrome secondary to pseudohypoparathyroidism.

Shehu Tea , Hoxha Violeta , Ylli Dorina , Ylli Agron

Background: Fahr’s Syndrome, also known as striopallidodentate calcinosis is a rare form of neurological disorder characterized by abnormal calcified deposits in basal ganglia, cerebellar and cerebral cortex. Its prevalence goes from 2 to 12.5%. Etiology of this disorder is very wide and involves endocrinopathy, mitochondrial myopathies dermatological abnormalities, infectious disease or may be idiopathic. We present a case of a patient with diffuse brain calcifications d...

ea0081ep242 | Calcium and Bone | ECE2022

Primary vs tertriary hyperparathyroidism in a patient with medullary nefrocalcinosis and chronic renal failure

Shehu Tea , Hoxha Violeta , Ylli Dorina , Cerma Adishah , Ylli Agron

Background: Nephrocalcinosis is characterized by the deposition of calcium products in kidney parenchyma and tubules. It may cause acute or chronic kidney injury or be incidentally detected radiographically in a patient with normal kidney function. Most patients with nephrocalcinosis do not progress to end-stage kidney disease, but with certain underlying conditions, may be associated with progressive kidney dysfunction.Methods: The patient was diagnosed...

ea0081ep1046 | Thyroid | ECE2022

Occult papillary thyroid carcinoma with lymphatic metastasis as first presentation of the disease - A report of two cases

Haxhiraj Adela , Cerma Adishah , Hoxha Violeta , Ylli Dorina , Ylli Agron

Introduction: Occult papillary carcinomas are small thyroid carcinomas (<1 cm) diagnosed after an initial manifestation of lymph nodes or distant metastasis. We report two cases of patients with this pattern of clinical presentation.Case description: The first case is a 21-year-old woman, with a one-year history of a growing cervical cyst. Fine needle aspiration of the cyst showed metastasis from papillary thyroid cancer. She had no previous history ...

ea0081ep1216 | Late Breaking | ECE2022

T4+T3 combination therapy of refractory hypothyroidism to levothyroxine treatment, in a subject after ablative radioactive iodine treatment for differentiated thyroid cancer. A case report and review of literature.

Kermaj Marjeta , Zaimi Irsa , Resuli Klotilda , Kapia Mariola , Ylli Agron

Introduction: Hypothyroidism is considered refractory to oral levothyroxine substitution, when there is biochemical (serum level of TSH (thyroid stimulating hormone) above the upper target level) or clinical evidence of hypothyroidism, despite increasing dosages of oral levothyroxine beyond 2.5 μg/kg daily. In these circumstances, further increments in the dosage of levothyroxine may not always be the most appropriate intervention. In such a situation, physicians need to ...